Western blotting demonstrated that ATV treatment led to an elevation of AMPK-α T172 phosphorylation accompanied by complete loss of Cav1 and GLUT3 expression in TKI-sensitive and -resistant NSCLC cells, compared to vehicle treated cells (Figure 5C). This evidence concerns the gene SLC2A3 and non-small cell lung carcinoma.